Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

Clinical trial NCT06311227 · RECRUITING

Trial details

NCT number: NCT06311227
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Hairy Cell Leukemia Recurrent Hairy Cell Leukemia Variant

Start date: 2024-12-16
Primary completion: 2027-05-20
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.